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The activation of signaling pathways involving protein tyrosine kinases (PTKs) has been demonstrated
during Trypanosoma cruzi invasion. Herein, we describe the participation of FAK/Src in the invasion of
cardiomyocytes by T. cruzi. The treatment of cardiomyocytes with genistein, a PTK inhibitor, signiﬁcantly
reduced T. cruzi invasion. Also, PP1, a potent Src-family protein inhibitor, and PF573228, a speciﬁc FAK
inhibitor, also inhibited T. cruzi entry; maximal inhibition was achieved at concentrations of 25 lM
PP1 (53% inhibition) and 40 lM PF573228 (50% inhibition). The suppression of FAK expression in siR-
NA-treated cells and tetracycline-uninduced Tet-FAK(WT)-46 cells signiﬁcantly reduced T. cruzi invasion.
The entry of T. cruzi is accompanied by changes in FAK and c-Src expression and phosphorylation. An
enhancement of FAK activation occurs during the initial stages of T. cruzi-cardiomyocyte interaction
(30 and 60 min), with a concomitant increase in the level of c-Src expression and phosphorylation,
suggesting that FAK/Src act as an integrated signaling pathway that coordinates parasite entry. These
data provide novel insights into the signaling pathways that are involved in cardiomyocyte invasion
by T. cruzi. A better understanding of the signal transduction networks involved in T. cruzi invasion
may contribute to the development of more effective therapies for the treatment of Chagas’ disease.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The invasion of mammalian cells is an essential step for the dis-
semination and persistence of many intracellular pathogens(Hauck et al., 2012; Sibley, 2011). The processes involved in Try-
panosoma cruzi invasion, the etiologic agent of Chagas’ disease,
have been intensely discussed in the last decade, and advances in
this ﬁeld have provided new insights into the mechanisms utilized
by T. cruzi to invade target cells (Butler et al., 2013; Calvet et al.,
2012; Caradonna and Burleigh, 2011; Nagajyothi et al., 2011).
The recognition of molecules on the host cell surface triggers
the activation of distinct signaling pathways, leading to a mecha-
nism of invasion that can be either dependent or independent of
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signaling cascades involving both tyrosine kinases and serine/thre-
onine phosphatases have also been described in the T. cruzi
invasion process (Maeda et al., 2012; Yoshida, 2006; Yoshida and
Cortez, 2008). A repertoire of molecules on the surface of the T. cruzi
is able to bind host cell receptors and to induce parasite invasion.
Receptor-ligand binding triggers the activation of protein tyrosine
kinase (PTK), phospholipase C (PLC), mTOR or kinin system in
mammalian cells, leading to intracellular Ca2+ mobilization and
parasite entry (Maeda et al., 2012; Scharfstein et al., 2000; Yoshida,
2006). The rise in transient cytoplasmic Ca2+ in host cells has been
shown to promote actin depolymerization at the parasite adhesion
site and activate a lysosome-dependent mechanism of invasion
(Tardieux et al., 1994; Yoshida, 2006). However, the participation
of the host cell cytoskeleton in this process has also been
clearly demonstrated; rapid actin remodeling (Butler et al., 2013;
Rosestolato et al., 2002) and the formation of host cell plasma
membrane extensions (Barbosa and Meirelles, 1995) enable the
engulfment of attached parasites. The phosphatidylinositol 3-kinase
(PI3K) pathway has also been shown to regulate T. cruzi entry
(Barrias et al., 2010; Vieira et al., 2002; Woolsey et al., 2003) and
may facilitate cross-talk with a number of other potential signaling
pathways, resulting in an intricate signaling network that may be
crucial for T. cruzi invasion.
Focal adhesion kinase (FAK), a non-receptor tyrosine kinase
(125 kDa), is activated by the clustering of integrins or heparan sul-
fate proteoglycans (HSPGs) (Bass and Humphries, 2002; Hall et al.,
2011; Schaller, 2010; Schaller et al., 1995). Autophosphorylation of
the Tyr397 residue of FAK potentially recruits SH2-containing pro-
teins, including PI3K and members of the Src kinase family (pri-
marily the c-Src protein), that promote the phosphorylation of
several FAK tyrosine residues (Guan, 2010; Parsons, 2003). c-Src
is a 60 kDa proto-oncogene, non-receptor tyrosine kinase that
has multiple substrates and promotes a diverse array of signaling
events (Johnson and Gallick, 2007). FAK-activation-mediated actin
remodeling is important in many biological functions, such as cell
cycle progression and migration (Hall et al., 2011).
Several pathogens, including viruses, fungi and bacteria, acti-
vate FAK and c-Src after association with integrins and/or HSPGs
on the surface of host cells (Boehm et al., 2011; Chen et al.,
2008; Kerur et al., 2010; Kim et al., 2012; Slanina et al., 2012;
Tegtmeyer et al., 2001). Because integrins and HSPGs have been
reported to mediate T. cruzi invasion (Bambino-Medeiros et al.,
2011; Calvet et al., 2003; Fernandez et al., 1993; Oliveira et al.,
2008), we investigated whether parasite entry triggers FAK/c-Src
signaling. Our observations that the interaction of T. cruzi with
cardiomyocytes induces an increase in FAK and c-Src expression
and phosphorylation and that parasite entry is impaired by speciﬁc
protein tyrosine kinase inhibitors (e.g., genistein, PP1 and
PF573228) and FAK repression systems (e.g., the silencing of FAK
with interference RNA or the use of Tet-FAK(WT)-46 cells in the
uninducible state) suggest that FAK and c-Src signaling are
involved in the T. cruzi invasion process. These data provide novel
insights into the signaling pathways that are involved in host cell
invasion by T. cruzi.2. Materials and methods
2.1. Cardiomyocyte culture
Cardiac muscle cells were isolated from 18 to 20-day-old mouse
embryos as previously described (Meirelles et al., 1986). Brieﬂy,
pregnant mice were obtained from Laboratory Animals Breeding
Center (CECAL, Fiocruz) and immediately submitted to euthanasia
by CO2 inhalation followed by cervical dislocation. Embryos wereremoved from the uterus, decapitated and fragments of cardiac tis-
sue were dissociated in phosphate-buffered saline (PBS) containing
0.025% trypsin (Sigma Aldrich, Saint Louis, MO) and 0.01% collage-
nase (Worthington Biochemical Corporation, Lakewood, NJ) at a pH
of 7.2. Subsequently, the isolated cells were either plated (at a den-
sity of 1.0  105 cells/ml) on 0.01% gelatin-coated glass cover slips
(Sigma Aldrich, Saint Louis, MO) in 24-well culture dishes or
seeded (at a density of 2.0  106 cells/ml) on gelatin-coated 60-
mm culture dishes for immunoblotting assays. The cultures were
maintained in Dulbecco’s Modiﬁed Eagle Medium (DMEM; Sigma
Aldrich, Saint Louis, MO) that was supplemented with 5% fetal bo-
vine serum (FBS; Sigma Aldrich, Saint Louis, MO), 2.5 mM CaCl2,
1 mM L-glutamine (Sigma Aldrich, Saint Louis, MO) and 2% chicken
embryo extract, applied as a source of growth factors (Pajtler et al.,
2010), and maintained at 37 C in a 5% CO2 atmosphere. All proce-
dures with animals were approved by the animal care and use
committee (license LW-37/13, Oswaldo Cruz Foundation).
2.2. Tet-FAK cells inducibly expressing FAK
Tet-FAK(WT)-46 cells are mouse embryo ﬁbroblasts that were
initially derived from FAK-null embryos and have been engineered
to inducibly express FAK under the control of the tetracycline
repression system (Owen et al., 1999). Tet-FAK(WT)-46 cells were
kindly provided by Dr. Steven Hanks (Department of Cell Biology,
Vanderbilt University School of Medicine, Nashville, Tennessee).
The cells were maintained in DMEM that was supplemented with
4500 mg/l D-glucose, 584 mg/l glutamine, 1 mM sodium pyruvate,
1 mM nonessential amino acids (all from GIBCO/BRL, Grand Island,
NY), 100 units/ml penicillin, 100 lg/ml streptomycin, 0.25 lg/ml
amphotericin B (Sigma Aldrich, Saint Louis, MO) and 10% fetal bo-
vine serum (FBS; Sigma Aldrich, Saint Louis, MO). Tetracycline (Cal-
biochem) was included at a concentration of 1 mg/ml to maintain
the Tet-FAK(WT)-46 cells in the uninduced state, and FAK expres-
sion was induced by tetracycline withdrawal for 2 days.
2.3. Cell culture-derived trypomastigotes and T. cruzi–host cell
interaction
Cultures of African green monkey kidney epithelial cells (Vero
cells) were maintained in RPMI 1640 medium (Cultilab, Campinas,
SP) that was supplemented with 5% FBS and 2% L-glutamine and
maintained at 37 C in a 5% CO2 atmosphere. After reaching
semi-conﬂuence, the cells were infected with culture-derived tryp-
omastigote forms of T. cruzi (clone Dm28c). Four days post-infec-
tion, the trypomastigotes that were released from ruptured T.
cruzi-infected Vero cells were harvested from the culture superna-
tant and used to infect cardiomyocyte cultures and Tet-FAK(WT)-
46 cells at a ratio of 20 parasites per host cell. The infections were
interrupted after 30, 60 and/or 120 min.
2.4. Tyrosine kinase inhibition assay
To test the effect of speciﬁc tyrosine kinase inhibitors on T. cruzi
invasion, cardiomyocyte cultures were incubated for 45 min at
37 C with non-toxic doses of genistein (25, 50 and 100 lM), a
tyrosine inhibitor; PP1 (4-amino-5-(4-methylphenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine; 1, 5, 10, 15, and 25 lM), a potent
inhibitor of Src-family tyrosine kinases; or PF573228 (10, 20 and
40 lM), a speciﬁc FAK inhibitor (Slack-Davis et al., 2007), in ser-
um-free DMEM prior to the addition of T. cruzi parasites. After
treatment, the cells were infected for 2 h with clone Dm28c try-
pomastigotes at a ratio of 20 parasites per host cell. After the inter-
action of parasites and host cells, the cultures were ﬁxed for 5 min
using Bouin’s solution (75 ml of saturated aqueous picric acid solu-
tion, 25 ml of 40% formaldehyde and 5 ml of glacial acetic acid),
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xylol series and mounted in Permount. The tyrosine kinase inhibi-
tors were dissolved in dimethyl sulfoxide (DMSO; Sigma Aldrich,
Saint Louis, MO). Neither the inhibitors nor the DMSO itself inter-
fered with the motility of the trypomastigotes or the spontaneous
beating of host cells during the course of the experiment. The per-
cent of infection was determined by quantiﬁcation of a minimum
of 200 cells in random selected microscopic ﬁelds using a Zeiss Axi-
oplan microscope. The tyrosine kinase inhibition assay was per-
formed three times in duplicate.
2.5. Transfection of FAK siRNA
A modiﬁed version of the manufacturer’s protocol was used for
the silencing of FAK with small-interference RNAs (siRNA, Santa
Cruz Biotechnology, CA). Brieﬂy, 1.5  105 or 2  106 cells seeded
into 24-well plates or 60-mm tissue culture dishes, respectively,
were transfected with lipofectamine (Invitrogen, Carlsbad, CA)
and 5 lg/ml of FAK siRNA (sc-35353; Santa Cruz) or control nonsi-
lencing siRNA (sc-37007; control siRNA-A from Santa Cruz). Solu-
tion A, which consisted of 1 ll of lipofectamine for every 25 ll of
OPTI-MEM (Invitrogen, Grand Island, NY), was incubated at room
temperature for 45 min. Solution B, consisting of 1 ll of FAK siRNA
for every 40 ll of OPTI-MEM, was then added to solution A. After
20 min of incubation, the mixture was applied to the cells in an
appropriate volume of OPTI-MEM. Twenty-four hours after trans-
fection, the cells were infected for 2 h with culture-derived try-
pomastigotes (clone Dm28c) at a ratio of 20 parasites per host
cell. Protein knockdown effectiveness was analyzed by immuno-
blotting after 24 h of siRNA transfection.
2.6. Protein extraction and immunoblotting assays
After parasite-host cell interaction, the cultures were washed
with cold PBS (pH 7.2) and lysed in lysis buffer (1% Triton X-100;
10 mM Tris–HCl, pH 7.4; 10 mM sodium pyrophosphate; 100 mM
sodium ﬂuoride; 10 lg/ml aprotinin; 1 mM PMSF; and 0.25 mM so-
dium orthovanadate). Loading buffer (62.5 mMTris–HCl, pH 6.8; 2%
SDS; 10% glycerol; 0.01% bromophenol blue; and 5% b-mercap-
toethanol) was added to cell lysates and heated at 100 C. The
amount of protein was quantiﬁed using the Follin–Lowry method,
and a total of 20 lg of protein was resolved by SDS–PAGE. Subse-
quently, the proteins were transferred to nitrocellulosemembranes
(BioRad, Hercules, CA) in transfer buffer (25 mM Tris–HCl; 192 mM
glycine; and 10% methanol, pH 8.3). The membrane was then
blockedwith 5% skimmilk in TBS containing 0.05% Tween 20 (TBST;
Sigma Aldrich, Saint Louis, MO) for 40 min prior to an overnight
incubation at 4 C with anti-FAK antibody (1:2000; Santa Cruz Bio-
technology, CA) or blocked with 5% BSA in TBST before a similar
incubation with either anti-pY397FAK (1:1000; Invitrogen, Frederick,
MD), anti-c-Src (1:500; Santa Cruz Biotechnology, CA) or anti-pY418
Src (1:2000;Millipore) antibodies. A loading control was performed
using mouse anti-GAPDH (36 kDa; Ambion, Inc.). After being
washed, the membranes were incubated with anti-rabbit IgG or
anti-mouse IgG HRP-labeled antibody (1:3000; Thermo Scientiﬁc,
Rockford, IL) for 1 h, washedwith TBST and incubatedwith chemol-
uminescent kit reagents (PIERCE; Thermo Scientiﬁc, Rockford, IL);
subsequently, the membranes were exposed to X-ray ﬁlm. Bands
corresponding to proteins of interest were quantiﬁed by optical
densitometry. The data shown represent the means of at least 3
independent experiments.
2.7. Statistical analysis
The ﬁlms were scanned, and densitometric analysis was per-
formed using ImageJ version 1.38 (Windows version of NIH Image,http://rsb.info.nih.gov/nih-image/). The results were normalized
by the GAPDH values for each sample in the same experiment. Stu-
dent’s t-test was used to determine the signiﬁcance of differences
between the means in the Western blot assays; a p value 60.05
was considered signiﬁcant.3. Results
3.1. FAK and Src are involved in T. cruzi invasion
Actin dynamics are regulated by numerous signaling pathways,
including protein tyrosine kinases (Gunst, 2004; Rohatgi et al.,
2001). Thus, because actin rearrangement plays a key role in T. cru-
zi invasion (Barbosa and Meirelles, 1995; Rosestolato et al., 2002),
we evaluated the involvement of tyrosine kinase phosphorylation
in regulating the entry of T. cruzi into cardiomyocytes. Tyrosin ki-
nases inhibitors were used as strategy to blockage non-receptor
tyrosin kinases (NRTK) (Fig. 1). Whole cell lysates were used to as-
sess the phosphorylation status of pY397FAK (Fig. 1A) and pY418Src
(Fig. 1B) after treatment of cardiomyocytes with tyrosine kinases
inhibitors. Western blot analysis revealed a signiﬁcant decrease
in the phosphorylation level of FAK and c-Src with genistein (a po-
tent general tyrosine kinase inhibitor), PP1 (a potent inhibitor of
Src-family tyrosine kinase) and PF573228 (a speciﬁc inhibitor of
FAK Tyr397 residue phosphorylation), but markedly lower level
was achieved in PF573228 (90%) and PP1 (59%) treatment. Then,
prior to infection for 2 h with clone Dm28c trypomastigotes, pri-
mary cultures of cardiomyocytes were pretreated with nontoxic
concentrations of genistein (25, 50 and 100 lM) for 45 min at
37 C. The inhibition of tyrosine kinases impaired the invasion of
cardiomyocytes by T. cruzi, leading to a signiﬁcant, dose-dependent
reduction of the observed infection levels (Fig. 1). A maximal inhi-
bition was achieved after treatment with 100 lM genistein
(Fig. 1C), resulting in a decrease in the infection level from 34%
(control value; p 6 0.0006) to 20%, representing an inhibition of
approximately 41%.
To investigate whether FAK signaling orchestrates T. cruzi entry,
we evaluated the effect of PF573228 on parasite invasion. A dose-
dependent reduction of parasite invasion was achieved when car-
diomyocyte cultures were treated with PF573228 prior to infection
(Fig. 1D). The lowest infection level (17%), compared to untreated
cells (35%), was achieved with the highest concentration of
PF573228 (40 lM), representing a 50% reduction in the invasion
of T. cruzi. Because the autophosphorylation of FAK (Tyr397 residue)
leads to the binding of Src-SH2 domain that promotes the up-
stream phosphorylation of FAK, we assessed the participation of
FAK/Src in T. cruzi invasion using PP1 a Src family tyrosine kinase
inhibitor. The treatment of cardiomyocytes with different concen-
trations of PP1 (1, 5, 10, 15 and 25 lM) led to a substantial,
dose-dependent decrease in T. cruzi invasion. The observed infec-
tion levels declined from approximately 34% to 16% (p 6 0.0006)
after treatment with the highest dose of PP1 (25 lM), corresponding
to a 53% inhibition (Fig. 1E).3.2. T. cruzi invasion induces FAK phosphorylation
To further determine whether the phosphorylated state of FAK
changes during T. cruzi invasion, we evaluated the ability of T. cruzi
to induce FAK phosphorylation at early stages of infection. Cardio-
myocyte cultures were infected with clone Dm28c trypomastigotes
for 30, 60 and 120 min, and total FAK and c-Src expression and
phosphorylation levels were evaluated by immunoblotting assays
(Fig. 2). Interesting, the initial stage of T. cruzi–host cell interaction,
which is associated with receptor-ligand recognition, corresponds
to an increase in pY397FAK, with signiﬁcant increases of 33%
Fig. 1. The effect of protein tyrosine kinases (PTKs) inhibitors on T. cruzi invasion. The treatment of cardiomyocytes with 100 lM genistein, 25 lM PP1 and 40 lM PF573228
led to a reduction of FAK (A) and Src (B) phosphorylation. Immunoblotting was performed with an anti-pY397FAK (A) and anti-Y418Src (B) antibodies. GAPDH was used as
internal control. The PTKs inhibitors block T. cruzi entry in a dose-dependent manner. (C) A maximal inhibition of T. cruzi invasion was achieved after treatment with 100 lM
genistein, which resulted in an inhibition of approximately 41%. (D) PF573228 treatment led to a 50% reduction in parasite invasion levels when cardiomyocyte cultures were
treated with a 40-lM dose of the inhibitor. (E) The infection levels also declined by 53% after treatment with a high dose of PP1 (25 lM). ⁄Represents p 6 0.05, as determined
using Student’s t-test.
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60 min of infection, respectively. Subsequently, pY397FAK levels re-
duced to steady-state levels compared to uninfected cardiomyo-
cyte cultures (Fig. 2B). Total FAK expression levels were not
altered by T. cruzi invasion (Fig. 2A), suggesting that T. cruzi infec-
tion did not affect FAK synthesis but instead induced the activation
of endogenous FAK. In contrast, the total expression level of c-Src
(60 kDa), a tyrosine kinase protein that is associated with FAK acti-
vation, was increased by approximately 2.0-fold at the early stages
of infection (30 and 60 min); this was followed by a signiﬁcant 22%
reduction (p 6 0.05) in c-Src levels after 120 min of infection in
comparison to the control cultures (Fig. 2C). Remarkably, the level
of pY418Src also increased after 30 min (86%, p 6 0.008) and 60 min
(93%, p 6 0.002) of T. cruzi infection (Fig. 2D). Like c-Src expression,
Src phosphorylation was also decreased at later time (120 min) of
infection (22%).
3.3. Knockdown of FAK impairs T. cruzi invasion
The role of FAK in T. cruzi invasion was also investigated using
small-interfering RNAs (siRNA) technology in transient assays.
Immunoblot analysis revealed that the transfection of cardiomyo-
cytes with 5 lg/ml of FAK siRNA efﬁciently reduced the expressionof FAK and the activation of pY397FAK by 80% and 84%, respec-
tively, in comparison with control siRNA or lipofectamine-un-
treated cells (Fig. 3A). The knockdown of FAK signiﬁcantly
suppressed the ability of cardiomyocytes to internalize the para-
sites, decreasing the infection level to 42% of the control (Fig. 3B).
The general aspect of control (Fig. 3C) and siRNA FAK treated car-
diomyocyte cultures (Fig. 3D) clearly demonstrates that down-
regulation of FAK inhibits parasite entry. This issue was also
investigated using a tetracycline repression system, Tet-
FAK(WT)-46 cells (WT-FAK cells), as a tool to evaluate the role
of FAK signaling in T. cruzi entry. WT-FAK cells that are treated
with tetracycline (WT-FAK-uninduced cells) are a suitable model
system because an identical inducible cell population serves as a
control. Therefore, WT-FAK cells were cultured in the presence or
absence of tetracycline for 48 h prior to T. cruzi infection (2 h). To
further conﬁrm the effect of tetracycline in FAK regulation, un-
treated and tetracycline-treated cells were examined by Western
blot. As shown in Fig. 4A, tetracycline treatment reduced both
expression and activation of FAK in Tet-FAK cells. In these cells,
the down-regulation of FAK after 48 h of tetracycline treatment
led to an 82% reduction of FAK and pY397FAK. The infection of
WT-FAK cells after 48 h of tetracycline treatment resulted in a
40% decrease in parasite invasion in comparison to the control
Fig. 2. FAK/SRC activity is involved in cardiomyocyte invasion by T. cruzi. The expression of FAK, c-SRC and phosphorylated FAK (pY397FAK) and Src (pY418Src) was evaluated
in non-infected (C) and Trypanosoma cruzi–infected cardiomyocytes (I) after 30, 60 and 120 min of interaction. Immunoblot assays revealed that T. cruzi induces FAK and Src
phosphorylation during the invasion process. Although FAK expression was not altered after infection (A), the level of pY397FAK increased by 33% and 36% after 30 and 60 min
of infection, respectively, and subsequently reduced to a steady-state level after 120 min (B). A 2-fold increase in c-Src expression (C) was associated with pY397FAK (B) and
pY418Src (D) enhancement, which also exhibited a decline after 120 min. The level of Src phosphorylation increased by 86% and 93% after 30 min and 60 min of infection,
respectively. The GAPDH signal was used to normalize loading differences between the lanes. Densitometric analyses were performed by normalizing FAK and Src expression
and phosphorylation to the simultaneously measured GAPDH levels. Protein/GAPDH = D.O. ⁄Represents p 6 0.05, as determined using Student’s t-test.
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(Fig. 4C) and uninducible T. cruzi-infected Tet-FAK cultures
(Fig. 4D) noticeably demonstrate that FAK down-regulation impairs
T. cruzi invasion.4. Discussion
Emerging evidence has revealed that protein tyrosine kinases
(PTKs) regulate critical early events during microbe infection.
Additionally, interactions between signal pathways have been
shown to enhance parasite invasion and, consequently, the success
of infections (Tegtmeyer et al., 2001). The involvement of Ca2+ in
signaling cascades has been shown to trigger the invasion of many
pathogens (Hu et al., 2005; TranVan Nhieu et al., 2004), including T.cruzi (Burleigh and Andrews, 1998). During T. cruzi–host cell inter-
actions, Ca2+ mobilization has been observed in both parasites and
target cells at early stages of infection (Maeda et al., 2012; Yoshida,
2006). In mammalian cells, the rise in transient cytosolic Ca2+ has
been shown to result from the release of Ca2+ from cellular com-
partments, such as the endoplasmic reticulum; this release is the
result of Ca2+ ATPase activation in response to protein G, phospho-
lipase C (PLC) and IP3 (Burleigh and Woolsey, 2002). In turn, the
involvement of FAK and Src in transmembrane receptor-activated
signaling pathways, primarily those of integrin and heparan sulfate
proteoglycan (Bass and Humphries, 2002; Schaller et al., 1995), has
also been shown to regulate Ca2+ channels. Because both integrin
and heparan sulfate proteoglycan (HSPG) mediate T. cruzi invasion
(Fernandez et al., 1993; Oliveira et al., 2008), protein tyrosine ki-
nases, including focal adhesion kinase (FAK) and Src, may play a
Fig. 3. RNA interference-mediated silencing of focal adhesion kinase inhibits T. cruzi invasion. Cardiomyocyte cultures were transfected for 24 h with siRNA targeting FAK. (A)
Immunoblotting assays conﬁrmed the knockdown of pY397FAK after siRNA transfection when compared to the control siRNA. GAPDH expression levels were determined as
controls. (B) The down-regulation of pY397FAK reduced T. cruzi invasion by 42% in comparison to untreated controls. (C, D) Image of T. cruzi-infected cardiomyocyte cultures
after transfection with control siRNA (C) or FAK siRNA (D). Note that FAK suppression reduces T. cruzi invasion (D), showing few intracellular parasites (arrow). The bars
represent the average of infection level of triplicate experiments ± SD. ⁄Represents p 6 0.05, as determined using Student’s t-test. Bar = 10 lm.
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sights into a potential role of FAK and Src activity in T. cruzi
invasion.
The treatment of cardiac muscle cells with genistein, an isoﬂav-
one that has been shown to be a highly-speciﬁc inhibitor of protein
tyrosine kinases (Akiyama and Ogawara, 1991), reduced the inva-
sion by T. cruzi in a dose-dependent manner. Our data are in accor-
dance with a previous report that also demonstrated the
involvement of host-cell PTK in T. cruzi entry (Procópio et al.,
1998). In addition, several studies have demonstrated the partici-
pation of PI3K in T. cruzi entry into both professional and non-pro-
fessional phagocytic cells (Vieira et al., 2002; Woolsey et al., 2003),
revealing that this parasite exploits cellular protein kinase signal-
ing pathways to enter target cells.
The participation of host cell kinases has also been reported as a
mechanism of invasion of a variety of pathogens (Hong et al., 2006;
Martiny et al., 1996; Monteiro da Silva et al., 2007). In similar stud-
ies that used kinase inhibitors, the invasion of the fungus Fonsecaea
pedrosoi, the principal etiologic agent of chromoblastomycosis, was
blocked by 77% and 52% when macrophages and epithelial cells,
respectively, were pretreated with genistein (Limongi et al.,
2003). In human brain microvascular endothelial cells (HBMEC),
the inhibition of PTKs by genistein decreased the uptake of Neisse-
ria meningitidis and inhibited the secretion of cytokines, such as
interleukin-6 (IL-6) and interleukin-8 (IL-8) (Sokolova et al.,
2004), suggesting that PTKs regulate important events in the inter-
actions between parasites and host cells. In addition, it has been
shown that PTK mediates the entry of Leishmania donovani prom-
astigotes into macrophages, a process that does not depend onparasite virulence, without interfering with intracellular parasite
proliferation (Ghosh and Chakraborty, 2002). Inhibition of PTKs
with genistein reduces Leishmania promastigote entry but also de-
creases the macrophages microbicidal activity, leading to enhance-
ment of parasite burden (Martiny et al., 1996). Phosphorylation of
proteins has also been evidenced in the invasion of Toxoplasma
gondii in macrophage (Ferreira et al., 2003). Treatment of macro-
phages or tachyzoites with genistein reduced the parasite entry,
suggesting that tyrosine kinases are involved in T. gondii–host cell
interaction.
We also attempted to determine whether FAK and c-Src signal-
ing pathways are activated during T. cruzi invasion. The treatment
of cardiomyocytes with PF573228 blocked FAK autophosphoryla-
tion (pY397FAK) and led to a 50% reduction in the entry of T. cruzi
parasites, suggesting a key role of the FAK signaling pathway in
the T. cruzi invasion process. Given that FAK activation is tightly
coupled with the generation of an active FAK/Src complex, which
determines the maximal catalytic activity of FAK (Parsons, 2003),
we used PP1, a Src-family tyrosine kinase inhibitor, to evaluate
the role of the FAK/Src complex in T. cruzi entry. Our results re-
vealed that FAK/Src inhibition impaired the invasion of cardiomyo-
cytes by T. cruzi, achieving a maximum inhibition (53%) after
treatment with 25 lM PP1, suggesting that cooperation between
FAK and Src drives the entry of T. cruzi into cardiomyocytes.
Dual-activation FAK-Src signaling orchestrates the remodeling
of the actin cytoskeleton and participates in the invasion mecha-
nisms of several pathogens (Reddy et al., 2000). The FAK/Src activa-
tion that is required for Staphylococcus aureus invasion is controlled
by the interaction between cell wall-attached ﬁbronectin-binding
Fig. 4. The suppression of FAK expression in tetracycline-uninduced Tet-FAK(WT)-46 cells signiﬁcantly reduced T. cruzi invasion. TetFAK cells were used to evaluate the
requirement of FAK activation in T. cruzi invasion. (A) The down-regulation of FAK and pY397FAK after 48 h of treatment of Tet-FAK(WT)-46 cells with tetracycline was
demonstrated by immunoblotting assays. (B) 48 h-Tetracycline treated Tet-FAK(WT)-46 cells (uninduced cells) exhibited a decrease in the level of T. cruzi infection, showing a
40% inhibition of parasite invasion. (C, D) General aspects of induced (C) and uninduced (D) Tet-FAK(WT)-46 cultures infected by T. cruzi (2 h), showing intracellular parasites
(arrows). Bars represent the average of infection level of triplicate experiments ± SD. ⁄Represents p 6 0.05, as determined using Student’s t-test. Bar = 20 lm.
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matrix protein ﬁbronectin (Agerer et al., 2003). Bacteria uptake is
inhibited in Src-deﬁcient cells, indicating that FAK/Src kinases reg-
ulate the cytoskeletal remodeling that enables the entry of bacte-
ria. Neisseria meningitides also induces FAK/Src complex and
cortactin activation and their cooperative interplay lead to endocy-
tosis of the bacteria by human brain microvascular endothelial
cells (Slanina et al., 2012). The binding of the IpA protein of Shigella
ﬂexneri to a5b1 integrin also promotes FAK activation, which stim-
ulates actin rearrangement at the bacterial adhesion site (Watarai
et al., 1996). Campylobacter jejuni also exploits integrin signal path-
way and FAK coordenates Rac1 GTPase activity for its entry in epi-
thelial cells (Boehm et al., 2011). The recruitment of FAK to focal
plates at sites of Escherichia coli invasion in brain microvascular
endothelium cells, in addition to evidence of FAK phosphorylation,
have demonstrated the important role of FAK in regulating actin
rearrangements during E. coli internalization (Reddy et al., 2000).
Activation of FAK also contributes to Cryptococcus neoformans
transmigration across the blood–brain barrier (Kim et al., 2012).
In malaria, red blood cells that are infected by protozoan Plasmo-
dium sp present proteins on their surfaces that activate Src and
FAK for subsequent MAPK activation, leading to the adherence of
infected cells to the endothelium, which impairs the removal of
parasitized cells by macrophages (Yipp et al., 2003).
To test whether the activation of FAK and Src is required for the
entry of T. cruzi into cardiomyocytes, we analyzed the expression of
Src, FAK and phosphorylated FAK ([pY397]-FAK) during T. cruzi–car-
diomyocyte interactions. Although the total FAK expression level
was unchanged, T. cruzi induced a signiﬁcant increase in FAK phos-
phorylation in cardiomyocytes. FAK phosphorylation takes place
during the initial stage of T. cruzi–cardiomyocyte interaction (30
and 60 min), with a concomitant increase in the level of Srcexpression and phosphorylation. Downstream of FAK phosphoryla-
tion, a corresponding reduction in Src expression after 2 h of inter-
action is observed, suggesting that FAK/Src are involved in an
integrated signaling pathway that coordinates parasite entry. Evi-
dence that T. cruzi parasites recognize both integrin and HSPG on
the surface of the target cells supports the idea that this parasite
activates the FAK/Src signaling pathway (Calvet et al., 2003;
Fernandez et al., 1993; Oliveira et al., 2008). The binding of parasite
surface ligands to host-cell transmembrane receptors may induce
FAK autophosphorylation and recruit Src, which ampliﬁes tyrosine
phosphorylation and results in actin rearrangement.
Integrin and HSPG have been implicated in the invasion path-
ways of a variety of pathogens (Chen et al., 2008). The association
of type 1 pili, the ﬁlamentous adhesive organelles of uropathogenic
E. coli, with a3b1 integrins elicits bacterial entry via FAK/Src activa-
tion and cortactin phosphorylation (Eto et al., 2007). Interestingly,
HSPG-integrin cooperation activates host cell signaling pathways
that are involved in the entry of Kaposi’s sarcoma-associated her-
pesvirus (Kerur et al., 2010; Veettil et al., 2006). Successive binding
of the viral envelope glycoprotein gpB to heparan sulfate and inte-
grin induces a signaling cascade that involves FAK, Src, PI3K and
RhoA GTPase, resulting in the uptake of the virus via endocytosis
(Veettil et al., 2006). The binding of human papillomavirus type
16 to heparan sulfate also triggers FAK activation through integrin
and mediates the virus infection in human adult keratinocytes cell
line (Abban and Meneses, 2010), reinforcing that HSPG-integrin
cooperation may also induce FAK signaling and elicit virus entry.
In addition, the attachment of Entamoeba histolytica trophozoites
to ﬁbronectin on the surface of endothelial cells triggers integrin-
dependent signaling through the association of FAK/Src, paxillin
and vinculin (Flores-Robles et al., 2003). An obligate intracellular
pathogen, Orientia tsutsugamushi, the causative agent of scrub
56 T.G. Melo et al. / Experimental Parasitology 139 (2014) 49–57typhus, activates integrin-mediated signal transduction pathways
including FAK/Src and induces actin rearrangements at the infec-
tion site in non-phagocytic host cells (Cho et al., 2010).
The knockdown of FAK expression by siRNA or the use of a tet-
racycline inducible system (i.e., Tet-FAK(WT)-46 cells) further
demonstrates the role of FAK signaling in the invasion of T. cruzi
parasites. The down-regulation of FAK through siRNA or tetracycline
treatment signiﬁcantly reduced trypomastigote internalization by
cardiomyocytes and uninduced Tet-FAK cells, respectively. The
speciﬁc transmembrane molecule responsible for the activation
of FAK signaling during cardiomyocyte invasion by T. cruzi is still
unknown; however, it may be coordinated by integrin, HSPG or
cross-talk between both receptors, as is observed in Kaposi’s
sarcoma-associated herpesvirus (Veettil et al., 2006) and Human
Papillomavirus Type 16 infections (Abban and Meneses, 2010),
because both surface molecules are known to elicit T. cruzi invasion
(Calvet et al., 2003; Fernandez et al., 1993). This issue will be the
focus of further investigations.
In summary, the results shown here demonstrated the role of
the FAK signaling pathway in the invasion of cardiomyocytes by
T. cruzi. The inhibition of total tyrosine kinase, FAK and Src tyrosine
kinase family activity by speciﬁc inhibitors impairs parasite entry.
The entrance of T. cruzi is associated with an increase in Src and
FAK phosphorylation and may modulate the actin cytoskeleton,
resulting in an endocytic invasion process. The previous observa-
tion of cardiomyocyte membrane extensions during T. cruzi inva-
sion and the inhibition of parasite entry upon treatment of these
cells with cytochalasin D (Barbosa and Meirelles, 1995) demon-
strate the involvement of the host cell cytoskeleton in parasite
internalization. This process may be regulated by FAK/Src activa-
tion and/or crosstalk between this signaling cascade and PI3K
and Rho GTPases. A better understanding of these pathways may
contribute to our knowledge of the molecular and cellular events
that occur during the interactions of T. cruzi parasites and cardio-
myocytes and may reveal new therapeutic targets for the treat-
ment of Chagas’ disease.
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